CD164 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	40 studies	43% ± 14%	Explore
natural killer cell	38 studies	42% ± 12%	Explore
fibroblast	36 studies	37% ± 14%	Explore
B cell	35 studies	31% ± 10%	Explore
endothelial cell	31 studies	29% ± 12%	Explore
CD8-positive, alpha-beta T cell	31 studies	30% ± 8%	Explore
T cell	27 studies	31% ± 9%	Explore
conventional dendritic cell	27 studies	39% ± 17%	Explore
CD4-positive, alpha-beta T cell	27 studies	30% ± 8%	Explore
smooth muscle cell	26 studies	32% ± 11%	Explore
pericyte	25 studies	35% ± 13%	Explore
plasmacytoid dendritic cell	24 studies	62% ± 19%	Explore
classical monocyte	24 studies	39% ± 14%	Explore
non-classical monocyte	23 studies	38% ± 16%	Explore
regulatory T cell	23 studies	35% ± 9%	Explore
monocyte	21 studies	35% ± 12%	Explore
epithelial cell	21 studies	46% ± 23%	Explore
mature NK T cell	20 studies	35% ± 11%	Explore
basal cell	19 studies	33% ± 18%	Explore
connective tissue cell	19 studies	38% ± 13%	Explore
memory B cell	18 studies	30% ± 8%	Explore
ciliated cell	18 studies	55% ± 18%	Explore
naive B cell	18 studies	29% ± 8%	Explore
gamma-delta T cell	18 studies	37% ± 10%	Explore
mast cell	17 studies	30% ± 12%	Explore
dendritic cell	16 studies	39% ± 22%	Explore
CD16-negative, CD56-bright natural killer cell, human	16 studies	40% ± 14%	Explore
plasma cell	15 studies	41% ± 16%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	50% ± 12%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	15 studies	28% ± 8%	Explore
myeloid cell	14 studies	42% ± 18%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	34% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	12 studies	31% ± 7%	Explore
myofibroblast cell	12 studies	38% ± 10%	Explore
mucosal invariant T cell	12 studies	32% ± 8%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	33% ± 12%	Explore
secretory cell	11 studies	34% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	33% ± 13%	Explore
goblet cell	11 studies	49% ± 20%	Explore
plasmablast	10 studies	41% ± 25%	Explore
abnormal cell	10 studies	32% ± 9%	Explore
endothelial cell of lymphatic vessel	9 studies	25% ± 6%	Explore
type I pneumocyte	9 studies	32% ± 12%	Explore
leukocyte	9 studies	33% ± 10%	Explore
progenitor cell	9 studies	39% ± 11%	Explore
hematopoietic stem cell	9 studies	50% ± 22%	Explore
endothelial cell of vascular tree	9 studies	23% ± 5%	Explore
alveolar macrophage	8 studies	55% ± 21%	Explore
type II pneumocyte	8 studies	27% ± 15%	Explore
innate lymphoid cell	8 studies	38% ± 10%	Explore
club cell	8 studies	31% ± 14%	Explore
capillary endothelial cell	8 studies	20% ± 4%	Explore
oligodendrocyte	8 studies	25% ± 9%	Explore
mesothelial cell	8 studies	33% ± 19%	Explore
vein endothelial cell	8 studies	22% ± 5%	Explore
microglial cell	8 studies	27% ± 13%	Explore
respiratory goblet cell	7 studies	30% ± 12%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	33% ± 8%	Explore
mononuclear phagocyte	7 studies	39% ± 19%	Explore
epithelial cell of proximal tubule	7 studies	43% ± 19%	Explore
endothelial cell of artery	7 studies	21% ± 4%	Explore
enterocyte	7 studies	43% ± 14%	Explore
T follicular helper cell	7 studies	33% ± 5%	Explore
ionocyte	6 studies	37% ± 13%	Explore
neutrophil	6 studies	21% ± 6%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	36% ± 10%	Explore
precursor B cell	6 studies	40% ± 17%	Explore
hematopoietic precursor cell	5 studies	62% ± 22%	Explore
kidney loop of Henle epithelial cell	5 studies	28% ± 6%	Explore
erythroblast	5 studies	47% ± 30%	Explore
pro-B cell	5 studies	32% ± 15%	Explore
brush cell	5 studies	31% ± 12%	Explore
immature B cell	5 studies	31% ± 5%	Explore
astrocyte	5 studies	30% ± 15%	Explore
adipocyte	5 studies	26% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	34% ± 6%	Explore
granulocyte	5 studies	35% ± 15%	Explore
deuterosomal cell	4 studies	20% ± 4%	Explore
duct epithelial cell	4 studies	26% ± 4%	Explore
platelet	4 studies	19% ± 1%	Explore
pancreatic A cell	4 studies	66% ± 15%	Explore
type B pancreatic cell	4 studies	48% ± 24%	Explore
exhausted T cell	4 studies	42% ± 6%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	45% ± 9%	Explore
renal alpha-intercalated cell	4 studies	43% ± 8%	Explore
enteroendocrine cell	4 studies	50% ± 18%	Explore
intestinal crypt stem cell	4 studies	39% ± 8%	Explore
transit amplifying cell	4 studies	38% ± 7%	Explore
lymphocyte	4 studies	32% ± 15%	Explore
neuroendocrine cell	4 studies	64% ± 26%	Explore
retinal pigment epithelial cell	4 studies	40% ± 23%	Explore
adventitial cell	4 studies	27% ± 10%	Explore
mucus secreting cell	4 studies	37% ± 20%	Explore
CD4-positive helper T cell	4 studies	24% ± 7%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	61% ± 8%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	63% ± 29%	Explore
erythrocyte	4 studies	38% ± 13%	Explore
group 3 innate lymphoid cell	4 studies	58% ± 8%	Explore
T-helper 17 cell	4 studies	30% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	33% ± 9%	Explore
squamous epithelial cell	3 studies	52% ± 19%	Explore
pancreatic D cell	3 studies	37% ± 18%	Explore
glomerular endothelial cell	3 studies	26% ± 5%	Explore
podocyte	3 studies	58% ± 8%	Explore
neural crest cell	3 studies	26% ± 8%	Explore
renal principal cell	3 studies	53% ± 5%	Explore
extravillous trophoblast	3 studies	62% ± 13%	Explore
placental villous trophoblast	3 studies	58% ± 4%	Explore
megakaryocyte	3 studies	37% ± 8%	Explore
serous secreting cell	3 studies	39% ± 14%	Explore
tissue-resident macrophage	3 studies	43% ± 11%	Explore
intraepithelial lymphocyte	3 studies	39% ± 14%	Explore
Mueller cell	3 studies	39% ± 10%	Explore
acinar cell	3 studies	51% ± 20%	Explore
muscle cell	3 studies	32% ± 15%	Explore
germinal center B cell	3 studies	31% ± 1%	Explore
intermediate monocyte	3 studies	45% ± 22%	Explore
IgA plasma cell	3 studies	20% ± 6%	Explore
myoepithelial cell	3 studies	28% ± 4%	Explore
neuron	3 studies	34% ± 13%	Explore
inflammatory macrophage	3 studies	32% ± 6%	Explore
luminal cell of prostate epithelium	3 studies	43% ± 11%	Explore
GABAergic neuron	3 studies	25% ± 5%	Explore
glutamatergic neuron	3 studies	38% ± 5%	Explore
pancreatic ductal cell	3 studies	68% ± 16%	Explore
glial cell	3 studies	37% ± 19%	Explore
T-helper 1 cell	3 studies	36% ± 1%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	40% ± 13%	Explore
double negative thymocyte	3 studies	45% ± 5%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	47% ± 11%	Explore
progenitor cell of mammary luminal epithelium	3 studies	28% ± 2%	Explore
hepatocyte	3 studies	53% ± 28%	Explore
oligodendrocyte precursor cell	3 studies	20% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	19 studies	37% ± 16%	Explore
lung	18 studies	40% ± 14%	Explore
intestine	11 studies	35% ± 16%	Explore
kidney	9 studies	34% ± 7%	Explore
liver	7 studies	32% ± 18%	Explore
brain	7 studies	32% ± 9%	Explore
pancreas	5 studies	47% ± 23%	Explore
bone marrow	5 studies	36% ± 18%	Explore
eye	5 studies	25% ± 6%	Explore
uterus	5 studies	40% ± 17%	Explore
lymph node	5 studies	30% ± 6%	Explore
placenta	4 studies	47% ± 18%	Explore
prostate	4 studies	27% ± 8%	Explore
breast	4 studies	33% ± 2%	Explore
adipose	3 studies	25% ± 5%	Explore
adrenal gland	3 studies	31% ± 8%	Explore
skin	3 studies	28% ± 6%	Explore
thymus	3 studies	39% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	10464.22	1445 / 1445	100%	183.24	183 / 183
prostate	100%	10725.52	245 / 245	100%	205.94	502 / 502
stomach	100%	12969.52	359 / 359	100%	221.35	286 / 286
breast	100%	15732.86	459 / 459	100%	270.41	1117 / 1118
lung	100%	12776.14	577 / 578	100%	167.14	1155 / 1155
intestine	100%	15936.84	966 / 966	100%	231.44	526 / 527
ovary	100%	11684.60	180 / 180	100%	129.02	428 / 430
thymus	100%	16862.66	653 / 653	100%	239.24	602 / 605
pancreas	100%	8922.42	327 / 328	99%	186.08	177 / 178
bladder	100%	12656.86	21 / 21	99%	160.47	499 / 504
uterus	100%	11170.93	170 / 170	99%	141.80	454 / 459
adrenal gland	100%	11779.77	258 / 258	99%	143.60	227 / 230
kidney	100%	11835.92	89 / 89	98%	156.70	887 / 901
liver	100%	9907.81	226 / 226	95%	84.18	386 / 406
skin	100%	14882.36	1808 / 1809	92%	104.94	434 / 472
brain	91%	4262.98	2406 / 2642	91%	67.69	645 / 705
adipose	100%	16082.97	1204 / 1204	0%	0	0 / 0
blood vessel	100%	15307.09	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	95.64	29 / 29
spleen	100%	11243.46	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	109.63	45 / 45
ureter	0%	0	0 / 0	100%	38.63	1 / 1
muscle	99%	7821.89	798 / 803	0%	0	0 / 0
heart	94%	6570.38	811 / 861	0%	0	0 / 0
peripheral blood	94%	12620.08	875 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	74%	64.87	59 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0007165	Biological process	signal transduction
GO_0006955	Biological process	immune response
GO_0007162	Biological process	negative regulation of cell adhesion
GO_0030097	Biological process	hemopoiesis
GO_0007155	Biological process	cell adhesion
GO_0007157	Biological process	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
GO_0007517	Biological process	muscle organ development
GO_0010008	Cellular component	endosome membrane
GO_0005764	Cellular component	lysosome
GO_0005768	Cellular component	endosome
GO_0005576	Cellular component	extracellular region
GO_0005886	Cellular component	plasma membrane
GO_0005765	Cellular component	lysosomal membrane
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	CD164
Protein name	CD164 variant C Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v) (CD antigen CD164) CD164 molecule
Synonyms
Description	FUNCTION: Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast migration and promotes myoblast fusion into myotubes (By similarity). .
Accessions	ENST00000512821.5 [Q04900-5] ENST00000324953.9 [Q04900-4] ENST00000504373.2 ENST00000310786.10 [Q04900-1] Q04900 Q5JSU3 ENST00000275080.11 [Q04900-3] D6R9B4 ENST00000413644.6 [Q04900-2]

CD164 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review